Dan Brennan

Stock Analyst at TD Cowen

(4.32)
# 442
Out of 5,044 analysts
114
Total ratings
58.06%
Success rate
15.14%
Average return

Stocks Rated by Dan Brennan

Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612$654
Current: $558.31
Upside: +17.14%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250$260
Current: $214.01
Upside: +21.49%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150$162
Current: $143.20
Upside: +13.13%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63$72
Current: $72.27
Upside: -0.37%
NeoGenomics
Sep 12, 2025
Maintains: Buy
Price Target: $10$12
Current: $10.28
Upside: +16.73%
Adaptive Biotechnologies
Aug 6, 2025
Maintains: Buy
Price Target: $13$15
Current: $16.80
Upside: -10.71%
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $29.43
Upside: +8.73%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135$110
Current: $131.76
Upside: -16.51%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8$2.5
Current: $3.07
Upside: -18.57%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $88.84
Upside: -16.70%
Maintains: Buy
Price Target: $82$86
Current: $62.74
Upside: +37.07%
Maintains: Buy
Price Target: $155$175
Current: $192.81
Upside: -9.24%
Maintains: Buy
Price Target: $240$250
Current: $180.15
Upside: +38.77%
Maintains: Hold
Price Target: $72$70
Current: $37.74
Upside: +85.48%
Maintains: Buy
Price Target: $166$177
Current: $95.03
Upside: +86.26%
Maintains: Buy
Price Target: $141$144
Current: $95.30
Upside: +51.10%
Maintains: Hold
Price Target: $363$410
Current: $343.47
Upside: +19.37%
Maintains: Hold
Price Target: $28$30
Current: $7.91
Upside: +279.27%
Maintains: Buy
Price Target: $28$31
Current: $11.58
Upside: +167.70%
Maintains: Buy
Price Target: $48$51
Current: $40.21
Upside: +26.83%
Initiates: Buy
Price Target: $56
Current: $6.54
Upside: +756.27%
Downgrades: Hold
Price Target: $57$32
Current: $12.90
Upside: +148.06%
Maintains: Outperform
Price Target: $545$546
Current: $170.30
Upside: +220.61%
Initiates: Outperform
Price Target: $7
Current: $4.81
Upside: +45.53%
Upgrades: Outperform
Price Target: $13$15
Current: $2.01
Upside: +646.27%
Upgrades: Buy
Price Target: $207$232
Current: $165.95
Upside: +39.80%
Downgrades: Sell
Price Target: $770$880
Current: $1,394.17
Upside: -36.88%